Greater Miami is rapidly emerging as an international biotech hot spot—as capital, talent, and infrastructure converge to transform the region from a tourism-driven economy into a globally connected life sciences innovation hub.
Raquel Cabo
Advertisement
Founder of Miami Biotech Collective.
Articles by Raquel Cabo
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Aradhana Sarin: The CFO as a Catalyst
2
Regeneron Enters $2.1 Billion Radiopharma Collaboration with Telix Pharmaceuticals
3
Pharmaceutical Executive Daily: FDA Issues Second CRL for Replimune's RP1 Melanoma Treatment
4
Managing Patient Experience and RWE in Clinical Trials: Q&A with Matt Holms, MB
5